MTOR and cancer: Recent studies have shown that the constitutive activation of the mTOR pathway, due to genetic changes like mutations, amplifications, or deletions in mTOR itself, its complexes (mTORC1 and mTORC2), or its upstream targets, plays a role in aging, neurological disorders, and various human cancers.